These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31562919)

  • 41. Mutational Analysis of Intracellular Loops Identify Cross Talk with Nucleotide Binding Domains of Yeast ABC Transporter Cdr1p.
    Shah AH; Rawal MK; Dhamgaye S; Komath SS; Saxena AK; Prasad R
    Sci Rep; 2015 Jun; 5():11211. PubMed ID: 26053667
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of the multi-drug efflux systems of pathogenic fungi using functional hyperexpression in Saccharomyces cerevisiae.
    Niimi M
    Nihon Ishinkin Gakkai Zasshi; 2010; 51(2):79-86. PubMed ID: 20467195
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Candida albicans Cdr2p ATP-binding cassette (ABC) transporter confers resistance to caspofungin.
    Schuetzer-Muehlbauer M; Willinger B; Krapf G; Enzinger S; Presterl E; Kuchler K
    Mol Microbiol; 2003 Apr; 48(1):225-35. PubMed ID: 12657057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deletion of transmembrane domain 12 of CDR1, a multidrug transporter from Candida albicans, leads to altered drug specificity: expression of a yeast multidrug transporter in baculovirus expression system.
    Krishnamurthy S; Chatterjee U; Gupta V; Prasad R; Das P; Snehlata P; Hasnain SE; Prasad R
    Yeast; 1998 Apr; 14(6):535-50. PubMed ID: 9605504
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulators of the Efflux Pump Cdr1p of Candida albicans: Mechanisms of Action and Chemical Features.
    Tran-Nguyen VK; Prasad R; Falson P; Boumendjel A
    Curr Med Chem; 2017; 24(30):3242-3253. PubMed ID: 28545374
    [TBL] [Abstract][Full Text] [Related]  

  • 46. cDNA microarray analysis of differential gene expression and regulation in clinically drug-resistant isolates of Candida albicans from bone marrow transplanted patients.
    Xu Z; Zhang LX; Zhang JD; Cao YB; Yu YY; Wang DJ; Ying K; Chen WS; Jiang YY
    Int J Med Microbiol; 2006 Oct; 296(6):421-34. PubMed ID: 16782404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Candida albicans CDR3 gene codes for an opaque-phase ABC transporter.
    Balan I; Alarco AM; Raymond M
    J Bacteriol; 1997 Dec; 179(23):7210-8. PubMed ID: 9393682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The PDR-type ABC transporters AtrA and AtrG are involved in azole drug resistance in Aspergillus oryzae.
    Miura D; Sugiyama K; Ito A; Ohba-Tanaka A; Tanaka M; Shintani T; Gomi K
    Biosci Biotechnol Biochem; 2018 Oct; 82(10):1840-1848. PubMed ID: 30011258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcription initiation of genes associated with azole resistance in Candida albicans.
    Harry JB; Song JL; Lyons CN; White TC
    Med Mycol; 2002 Feb; 40(1):73-81. PubMed ID: 11860016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The putative ABC transporter encoded by the orf19.4531 plays a role in the sensitivity of Candida albicans cells to azole antifungal drugs.
    Jiang L; Xu D; Chen Z; Cao Y; Gao P; Jiang Y
    FEMS Yeast Res; 2016 May; 16(3):. PubMed ID: 26975389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ABC transporter Cdr1p harbors charged residues in the intracellular loop and nucleotide-binding domain critical for protein trafficking and drug resistance.
    Shah AH; Banerjee A; Rawal MK; Saxena AK; Mondal AK; Prasad R
    FEMS Yeast Res; 2015 Aug; 15(5):fov036. PubMed ID: 26048893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility.
    Niimi K; Maki K; Ikeda F; Holmes AR; Lamping E; Niimi M; Monk BC; Cannon RD
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1148-55. PubMed ID: 16569823
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Newly identified motifs in Candida albicans Cdr1 protein nucleotide binding domains are pleiotropic drug resistance subfamily-specific and functionally asymmetric.
    Rawal MK; Banerjee A; Shah AH; Khan MF; Sen S; Saxena AK; Monk BC; Cannon RD; Bhatnagar R; Mondal AK; Prasad R
    Sci Rep; 2016 Jun; 6():27132. PubMed ID: 27251950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blocking and dislocation of Candida albicans Cdr1p transporter by styrylquinolines.
    Szczepaniak J; Cieślik W; Romanowicz A; Musioł R; Krasowska A
    Int J Antimicrob Agents; 2017 Aug; 50(2):171-176. PubMed ID: 28602766
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ABC proteins in yeast and fungal pathogens.
    Klein C; Kuchler K; Valachovic M
    Essays Biochem; 2011 Sep; 50(1):101-19. PubMed ID: 21967054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of multidrug efflux systems on methylene blue-mediated photodynamic inactivation of Candida albicans.
    Prates RA; Kato IT; Ribeiro MS; Tegos GP; Hamblin MR
    J Antimicrob Chemother; 2011 Jul; 66(7):1525-32. PubMed ID: 21525022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beauvericin Potentiates Azole Activity via Inhibition of Multidrug Efflux, Blocks Candida albicans Morphogenesis, and Is Effluxed via Yor1 and Circuitry Controlled by Zcf29.
    Shekhar-Guturja T; Tebung WA; Mount H; Liu N; Köhler JR; Whiteway M; Cowen LE
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7468-7480. PubMed ID: 27736764
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heteroresistance to Fluconazole Is a Continuously Distributed Phenotype among Candida glabrata Clinical Strains Associated with In Vivo Persistence.
    Ben-Ami R; Zimmerman O; Finn T; Amit S; Novikov A; Wertheimer N; Lurie-Weinberger M; Berman J
    mBio; 2016 Aug; 7(4):. PubMed ID: 27486188
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Repurposing the anthelminthic salicylanilide oxyclozanide against susceptible and clinical resistant Candida albicans strains.
    Pic E; Burgain A; Sellam A
    Med Mycol; 2019 Apr; 57(3):387-390. PubMed ID: 29762783
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Purification and characterization of the N-terminal nucleotide binding domain of an ABC drug transporter of Candida albicans: uncommon cysteine 193 of Walker A is critical for ATP hydrolysis.
    Jha S; Karnani N; Dhar SK; Mukhopadhayay K; Shukla S; Saini P; Mukhopadhayay G; Prasad R
    Biochemistry; 2003 Sep; 42(36):10822-32. PubMed ID: 12962507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.